These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 11158464
1. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Lester BM, ElSohly M, Wright LL, Smeriglio VL, Verter J, Bauer CR, Shankaran S, Bada HS, Walls HH, Huestis MA, Finnegan LP, Maza PL. Pediatrics; 2001 Feb; 107(2):309-17. PubMed ID: 11158464 [Abstract] [Full Text] [Related]
4. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA. Ther Drug Monit; 2009 Dec; 31(6):769-75. PubMed ID: 19935364 [Abstract] [Full Text] [Related]
5. Cocaine and opiates use in pregnancy: detection of drugs in neonatal meconium and urine. López P, Bermejo AM, Tabernero MJ, Cabarcos P, Alvarez I, Fernández P. J Anal Toxicol; 2009 Sep; 33(7):351-5. PubMed ID: 19796504 [Abstract] [Full Text] [Related]
7. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ. J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697 [Abstract] [Full Text] [Related]
8. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads. Stabler M, Giacobbi P, Chertok I, Long L, Cottrell L, Yossuck P. Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537 [Abstract] [Full Text] [Related]
10. Determination of the prevalence of drug misuse by meconium analysis. Williamson S, Jackson L, Skeoch C, Azzim G, Anderson R. Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733 [Abstract] [Full Text] [Related]
11. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy. Concheiro M, Lendoiro E, de Castro A, Gónzalez-Colmenero E, Concheiro-Guisan A, Peñas-Silva P, Macias-Cortiña M, Cruz-Landeira A, López-Rivadulla M. Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432 [Abstract] [Full Text] [Related]
13. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend. Yawn BP, Thompson LR, Lupo VR, Googins MK, Yawn RA. Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532 [Abstract] [Full Text] [Related]
14. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses. DiGregorio GJ, Ferko AP, Barbieri EJ, Ruch EK, Chawla H, Keohane D, Rosenstock R, Aldano A. J Anal Toxicol; 1994 Sep; 18(5):247-50. PubMed ID: 7990440 [Abstract] [Full Text] [Related]
15. Determination of drugs of abuse in meconium. Moore C, Negrusz A, Lewis D. J Chromatogr B Biomed Sci Appl; 1998 Aug 21; 713(1):137-46. PubMed ID: 9700556 [Abstract] [Full Text] [Related]
18. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA. Marin SJ, Keith L, Merrell M, McMillin GA. J Anal Toxicol; 2009 Apr 21; 33(3):148-54. PubMed ID: 19371463 [Abstract] [Full Text] [Related]
20. Adaptation of the meconium drug test for mass screening. Ostrea EM, Romero A, Yee H. J Pediatr; 1993 Jan 21; 122(1):152-4. PubMed ID: 8419604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]